IFM Investors Pty Ltd increased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 179,913 shares of the healthcare conglomerate's stock after purchasing an additional 4,636 shares during the period. UnitedHealth Group accounts for 0.5% of IFM Investors Pty Ltd's portfolio, making the stock its 26th biggest position. IFM Investors Pty Ltd's holdings in UnitedHealth Group were worth $56,127,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of UNH. Vanguard Group Inc. lifted its stake in shares of UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP raised its position in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares in the last quarter. GAMMA Investing LLC grew its stake in UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Bank of New York Mellon Corp grew its stake in UnitedHealth Group by 2.5% during the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock valued at $4,257,131,000 after purchasing an additional 196,696 shares during the last quarter. Finally, Nuveen LLC purchased a new stake in shares of UnitedHealth Group in the first quarter worth about $3,846,764,000. 87.86% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Stock Performance
UnitedHealth Group stock traded up $1.90 during midday trading on Friday, hitting $336.72. 13,528,738 shares of the company were exchanged, compared to its average volume of 13,748,202. The firm has a market capitalization of $304.96 billion, a PE ratio of 14.59, a price-to-earnings-growth ratio of 2.19 and a beta of 0.45. The business has a fifty day simple moving average of $295.67 and a two-hundred day simple moving average of $365.19. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same period in the previous year, the firm earned $6.80 earnings per share. The company's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group's payout ratio is presently 38.30%.
Analysts Set New Price Targets
A number of equities analysts have commented on the company. Morgan Stanley increased their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. Wells Fargo & Company cut their price target on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. KeyCorp cut their target price on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Barclays lifted their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a report on Thursday, September 4th. Finally, Cantor Fitzgerald reissued an "overweight" rating and set a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $358.95.
Read Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.